Rafael Najmanovich
@rnajmanovich.bsky.social
200 followers 340 following 30 posts
Structural bioinformatics, computational biophysics, drug design, protein dynamics at University of Montreal. In my free time I create bonsai trees and care for these and other fantastic beasts (reptiles, amphibians and tarantulas).
Posts Media Videos Starter Packs
rnajmanovich.bsky.social
It was a great meeting. Thank you @gonzaparra.bsky.social for making sure every detail worked out - except for the rain... :)
gonzaparra.bsky.social
Everything comes to an end but memories remain!!
We had a great 3DSIG/3DBioinfo event in "sunny" Barcelona this week!! I have enjoyed so much to help organising it & to have such great minds all together sharing science for 3 days!!

Aufwiedersehen friends! For more science & friendships to come! ⭐
rnajmanovich.bsky.social
NRGRank, with which you can screen 10^6 molecules per day in a modern laptop, is out. Particularly useful for apo form or AlphaFold models but in all cases (including hole), finding binders that are missed by Glide (the opposite is also true). NRGRank requires 0.3s/compound - 100-1000 fold faster.
rnajmanovich.bsky.social
was going to send you a DM as I prefer not to discuss politics in public but found out your profile does not allow DMs.
rnajmanovich.bsky.social
Happy to share our latest preprint. With NRGRank you can screen 1M in a day in a laptop (use our NEGSuite-Qt for that) - a billion compounds per day with our computational resources.
biorxiv-biophys.bsky.social
NRGRank: Coarse-grained structurally-informed ultra-massive virtual screening https://www.biorxiv.org/content/10.1101/2025.02.17.638675v1
rnajmanovich.bsky.social
"We demonstrate that current co-folding approaches largely memorise ligand poses from their training data, hindering their use for de novo drug design."
Reposted by Rafael Najmanovich
florianjug.bsky.social
🚨🚨 MEGA JOB ALERT 🚨🚨
Independent Group Leader Positions in Computational Biology @humantechnopole.bsky.social!

Are you ready to start your own lab? Do you know someone who is? Repost this + share with everyone who might want to know about it. Thanks!!! 🙏

More details below... check it out! 🧵 1/3
Reposted by Rafael Najmanovich
dougkojetin.bsky.social
In The Pipeline blog featuring estrogen receptor papers with contributions from @nrimpact.bsky.social members @docfanning.bsky.social and @nelsonlab.bsky.social #nuclearreceptors
dereklowe.bsky.social
This one is mostly about the title subject (featuring a very interesting compound from academia) but it’s also about attacking the NIH:
Attacking Estrogen-Receptor-Positive Breast Cancer
www.science.org
rnajmanovich.bsky.social
I don'y like mate but I like this paper, what a monumental achievement, from genome to structure/function. Wow.
rnajmanovich.bsky.social
let alone that any health intervention may take upwards of 15 years alone to be approved...
rnajmanovich.bsky.social
Our newest preprint is out. A PyMOL plugin giving access to a broad suite of high-performance, fast, and easy to use methods for virtual screening (50K molecules/h), docking, analysis of molecular interactions, dynamics, engineering permitting complex workflows.
biorxiv-biophys.bsky.social
NRGSuite-Qt: A PyMOL plugin for high-throughput virtual screening, molecular docking, normal-mode analysis, the study of molecular interactions and the detection of binding-site similarities https://www.biorxiv.org/content/10.1101/2025.01.23.634566v1
rnajmanovich.bsky.social
It is happening to our preprint too, It is a new outreach program to expand the visibility of research - people interested in our research get to hear about someone else's upon reading what was supposed to be our abstract... and someone else is reading our abstracts elsewhere too.
rnajmanovich.bsky.social
Thanks Nathanael - we need to catch up - I am aware I let the ball drop on that email you sent me long ago. Can we do a zoom in the new year?
Reposted by Rafael Najmanovich
elife.bsky.social
After listening to community feedback, we will provide a partial feed allowing 93% of eLife authors to continue being indexed in the Web of Science Core Collection. We will also move from the Scopus Journals Collection to the Scopus Preprints Collection.

Full update below.
Changes to eLife’s indexing status in Web of Science and Scopus
To best serve the needs of researchers, eLife will provide a partial feed of research to be indexed in the Web of Science Core Collection. eLife will also move from the Scopus Journals Collection to…
buff.ly
rnajmanovich.bsky.social
(5/5) We characterize the patterns of glycosylation and its role in mediating Ab binding and conformational stability. This study was performed entirely with experimental structures, 1560 in total and without the incredible efforts of the structural community it would not have been possible.
rnajmanovich.bsky.social
(4/N) Enthalpic trade-off mutations in the RBM favour immune escape at the expense of ACE2 binding, whereas entropic trade-off mutations do not affect RBM but favour the closed state, thus entropically decreasing ACE2 binding.
rnajmanovich.bsky.social
(3/N) We perform a longitudinal analysis of the effect of mutations, we show the changing epistatic effect of mutations, define two evolutionary trade-off hypotheses for viral evolution: Enthalpic and Entropic.
rnajmanovich.bsky.social
(2/N) We use a combination of Surfaces' energies and geometry to define 14 epitope classes that go beyond Barnes' classes